Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
3
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
study
3
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trial
prescriptions
2025
ad-comm
affimed
akcea therapeutics
alirocumab
allogene therapeutics
amgen
amicus therapeutics
antidepressant
approval
What
new
3
×
cancer
allogene
bio
centers
cholesterol
crispr
cut
depression
diversity
drug
drugs
event
expensive
faces
financial
foe
genetic
guesswork
guide
healthcare
helps
hint
hot
immunotherapy
inhibitors
investors
ipo
juno
known
lowering
major
making
medical
medicine
million
nearly
pcsk
practice
precise
Language
unset
Current search:
new
×
study
×
" new york blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?